Luthria, Gaurav http://orcid.org/0000-0002-7896-6134
Li, Ran http://orcid.org/0000-0002-8537-8824
Wang, Stephanie
Prytyskach, Mark
Kohler, Rainer H. http://orcid.org/0000-0001-6269-6590
Lauffenburger, Douglas A. http://orcid.org/0000-0002-0050-989X
Mitchison, Timothy J.
Weissleder, Ralph http://orcid.org/0000-0003-0828-4143
Miller, Miles A. http://orcid.org/0000-0001-7638-8898
Funding for this research was provided by:
National Science Foundation (Graduate Research Fellowship Program)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R00CA207744, U01CA206997, T32CA079443)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
American Thyroid Association
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM069668)
Article History
Received: 4 June 2019
Accepted: 2 June 2020
First Online: 14 July 2020
Competing interests
: R.W. is a co-founder of T2Biosystems and Lumicell, serves as a scientific advisor for ModeRNA Therapeutics, Tarveda Therapeutics, Accure Health and Aikili Biosystems. None of these activities are related to the manuscript. The other authors declare that they have no competing interests.